Sevelamer Carbonate is indicated for the control of serum phosphorous in patient with chronic kidney disease (CKD) on dialysis. It is also indicated for the control of hyperphosphatemia in adult patients receiving hemodialysis or peritoneal dialysis. It is also approved for adult CKD patients not on dialysis with serum phosphorous >1.78 mmol/L.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
